PhRMA Taps Former NIH Senior Advisor As Science And Regulatory VP

The Pharmaceutical Research and Manufacturers of America (PhRMA) tapped a prior senior advisor at the National Institutes of Health, Rajesh Ranganathan, as its new vice president of science and regulatory advocacy, the group announced Friday (July 31). He will start his new position on Aug. 3. Ranganathan was previously the direct of translational research at the National Institute for Neurological Disorders and Stroke, where he led efforts to quickly and effectively convert basic and translational research results into new therapies...